{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:05:14Z","timestamp":1769069114616,"version":"3.49.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.3816\/ccc.2008.n.032","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:06:51Z","timestamp":1221080811000},"page":"247-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Regional Chemotherapy for Liver-Limited Metastatic Colorectal Cancer"],"prefix":"10.3816","volume":"7","author":[{"given":"Derek G.","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Healey-Bird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2008.n.032_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","article-title":"Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie","volume":"77","author":"Nordlinger","year":"1996","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"issue":"14 suppl","key":"10.3816\/CCC.2008.n.032_bib4","first-page":"248","article-title":"Cetuximab+FOLFIRI as first line treatment for metastatic colorectal cancer","volume":"22","author":"Rougier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib5","first-page":"3784","article-title":"A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2\u2032-deoxyuridine and 5-fluorouracil","volume":"38","author":"Ensminger","year":"1978","journal-title":"Cancer Res"},{"key":"10.3816\/CCC.2008.n.032_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","article-title":"Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure","volume":"15","author":"Boige","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib7","first-page":"743","article-title":"Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer","volume":"20","author":"Del Freo","year":"2006","journal-title":"In Vivo"},{"key":"10.3816\/CCC.2008.n.032_bib8","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","article-title":"Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer","volume":"23","author":"Ducreux","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CCC.2008.n.032_bib9","first-page":"178s","article-title":"Predictors of a true complete response in colorectal liver metastases that disappear radiographically following chemotherapy","volume":"25","author":"Taylor","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib10","first-page":"1680","article-title":"Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer","volume":"48","author":"Nakajima","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.3816\/CCC.2008.n.032_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/ejso.2002.1421","article-title":"Patterns of failure following curative resection of colorectal liver metastases","volume":"29","author":"Topal","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/1096-9098(200102)76:2<127::AID-JSO1023>3.0.CO;2-Z","article-title":"Repeat hepatectomy for colorectal liver metastases: A worthwhile operation?","volume":"76","author":"Muratore","year":"2001","journal-title":"J Surg Oncol"},{"issue":"14 suppl","key":"10.3816\/CCC.2008.n.032_bib13","first-page":"300","article-title":"Hepatic artery chronomodulated infusion of irinotecan, 5-fluorouracil and oxaliplatin against liver metastases in heavily pretreated patients with colorectal cancer","volume":"22","author":"Bouchahda","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1011186708754","article-title":"Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer","volume":"12","author":"Kern","year":"2001","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/030089160308900406","article-title":"Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study","volume":"89","author":"Fiorentini","year":"2003","journal-title":"Tumori"},{"key":"10.3816\/CCC.2008.n.032_bib16","first-page":"405","article-title":"Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study","volume":"8","author":"van Riel","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"14 suppl","key":"10.3816\/CCC.2008.n.032_bib17","first-page":"298","article-title":"A phase I study of hepatic arterial infusion (HAI) of irinotecan in patients with inoperable liver metastases of colorectal cancer","volume":"22","author":"Vogl","year":"2004","journal-title":"J Clin Oncol"},{"issue":"suppl 5","key":"10.3816\/CCC.2008.n.032_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/1120009X.2004.11782384","article-title":"Limited potential of hepatic arterial infusion of irinotecan","volume":"16","author":"De Jong","year":"2004","journal-title":"J Chemother"},{"key":"10.3816\/CCC.2008.n.032_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdh022","article-title":"Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver","volume":"15","author":"van Riel","year":"2004","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib20","first-page":"1917","article-title":"Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer","volume":"23","author":"Mancuso","year":"2003","journal-title":"Anticancer Res"},{"key":"10.3816\/CCC.2008.n.032_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1054\/bjoc.2001.1972","article-title":"Liver metastases from colorectal cancer: regional intra-arterial treatment following failure of systemic chemotherapy","volume":"85","author":"Cyjon","year":"2001","journal-title":"Br J Cancer"},{"issue":"1 suppl","key":"10.3816\/CCC.2008.n.032_bib22","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1067\/msy.2002.119364","article-title":"Protracted hepatic arterial infusion with low-dose cisplatin plus 5-fluorouracil for unresectable liver metastases from colorectal cancer","volume":"131","author":"Kohnoe","year":"2002","journal-title":"Surgery"},{"key":"10.3816\/CCC.2008.n.032_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/ejso.1999.0661","article-title":"Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases","volume":"25","author":"Link","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3748\/wjg.v8.i4.663","article-title":"Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer","volume":"8","author":"Liu","year":"2002","journal-title":"World J Gastroenterol"},{"issue":"18 suppl","key":"10.3816\/CCC.2008.n.032_bib25","first-page":"626s","article-title":"A phase I clinical and pharmacokinetic study of escalating doses of fixed rate and escalating infusion duration of gemcitabine given via an intrahepatic pump for patients with hepatic metastases","volume":"24","author":"Tse","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/annonc\/mdg404","article-title":"Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)","volume":"14","author":"Zelek","year":"2003","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib27","first-page":"6070","article-title":"Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints","volume":"62","author":"Reid","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CCC.2008.n.032_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1089\/hum.2006.17.1214","article-title":"Phase I, open-label, doseescalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver","volume":"17","author":"Kemeny","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.3816\/CCC.2008.n.032_bib29","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1200\/JCO.2006.07.9244","article-title":"Benefits and risks of neoadjuvant therapy for liver metastases","volume":"24","author":"Nordlinger","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib30","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ejca.2006.04.012","article-title":"Towards a pan-European consensus on the treatment of patients with colorectal liver metastases","volume":"42","author":"Van Cutsem","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/annonc\/mdh217","article-title":"Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients","volume":"15","author":"Pozzo","year":"2004","journal-title":"Ann Oncol"},{"issue":"18 suppl","key":"10.3816\/CCC.2008.n.032_bib32","first-page":"164s","article-title":"Long-term follow-up of colorectal cancer (CRC) patients treated with neoadjuvant chemotherapy with irinotecan and fluorouracil plus folinic acid (5-FU\/FA) for unresectable liver metastases","volume":"24","author":"Pozzo","year":"2006","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CCC.2008.n.032_bib33","first-page":"164s","article-title":"Randomized phase III study of irinotecan and 5-FU\/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial","volume":"25","author":"Van Cutsem","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib34","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1200\/JCO.2007.13.2183","article-title":"Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer","volume":"25","author":"Tabernero","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib35","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1245\/s10434-007-9482-9","article-title":"Outcome of posthepatectomymissing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection","volume":"7","author":"Kooby","year":"2003","journal-title":"J Gastrointest Surgery"},{"key":"10.3816\/CCC.2008.n.032_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jamcollsurg.2005.09.010","article-title":"Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases","volume":"202","author":"Rubbia-Brandt","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.3816\/CCC.2008.n.032_bib38","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib40","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.3816\/CCC.2008.n.032_bib41","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.3816\/CCC.2008.n.032_bib42","series-title":"Clinical Oncology","first-page":"1141","article-title":"Liver metastases","author":"Kemeny","year":"2004"},{"key":"10.3816\/CCC.2008.n.032_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0360-3016(84)90295-5","article-title":"Local failure following curative resection of colonic adenocarcinoma","volume":"10","author":"Willett","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CCC.2008.n.032_bib44","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2004.03.104","article-title":"Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis","volume":"22","author":"Thirion","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib45","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1200\/JCO.2006.06.1317","article-title":"Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial","volume":"24","author":"Goldberg","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2008.n.032_bib48","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2008.n.032_bib49","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib50","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"key":"10.3816\/CCC.2008.n.032_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM196402132700701","article-title":"Chemotherapy of Metastatic Liver Cancer by Prolonged Hepatic-Artery Infusion","volume":"270","author":"Sullivan","year":"1964","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2008.n.032_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1098-2388(200009)19:2<125::AID-SSU5>3.0.CO;2-E","article-title":"Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma","volume":"19","author":"Koea","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib53","first-page":"176","article-title":"Clinical pharmacology of hepatic arterial chemotherapy","volume":"10","author":"Ensminger","year":"1983","journal-title":"Semin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sonc.2002.31679","article-title":"Intrahepatic arterial infusion of chemotherapy: pharmacologic principles","volume":"29","author":"Ensminger","year":"2002","journal-title":"Semin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/978-3-642-82635-1_30","article-title":"Intraarterial chemotherapy for colorectal liver metastases and hepatomas using a totally implantable drug infusion pump","volume":"100","author":"Balch","year":"1986","journal-title":"Recent Results Cancer Res"},{"key":"10.3816\/CCC.2008.n.032_bib56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9610(83)90053-3","article-title":"Regional hepatic chemotherapy using an implantable drug infusion pump","volume":"145","author":"Cohen","year":"1983","journal-title":"Am J Surg"},{"key":"10.3816\/CCC.2008.n.032_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1200\/JCO.1984.2.6.595","article-title":"Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma","volume":"2","author":"Kemeny","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib58","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/1097-0142(19840315)53:6<1336::AID-CNCR2820530620>3.0.CO;2-O","article-title":"Regional chemotherapy of colorectal cancer metastatic to the liver","volume":"53","author":"Niederhuber","year":"1984","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00000658-198505000-00004","article-title":"Assessment of treatment of intrahepatic malignancies using chemotherapy via an implantable pump","volume":"201","author":"Schwartz","year":"1985","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1200\/JCO.1985.3.2.161","article-title":"Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump","volume":"3","author":"Shepard","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.1983.1.5.337","article-title":"Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump","volume":"1","author":"Weiss","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/88.5.252","article-title":"Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer","volume":"88","author":"Cancer","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CCC.2008.n.032_bib63","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1639::AID-CNCR1>3.0.CO;2-9","article-title":"Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature","volume":"78","author":"Harmantas","year":"1996","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib64","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(94)90750-1","article-title":"Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases","volume":"344","author":"Allen-Mersh","year":"1994","journal-title":"Lancet"},{"key":"10.3816\/CCC.2008.n.032_bib65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","article-title":"A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases","volume":"206","author":"Chang","year":"1987","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib66","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","article-title":"A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial","volume":"7","author":"Hohn","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","article-title":"Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial","volume":"107","author":"Kemeny","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.3816\/CCC.2008.n.032_bib68","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","article-title":"Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial","volume":"125","author":"Martin","year":"1990","journal-title":"Arch Surg"},{"key":"10.3816\/CCC.2008.n.032_bib69","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"10","author":"Rougier","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib70","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.1990.8.11.1885","article-title":"A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver","volume":"8","author":"Wagman","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(03)12388-4","article-title":"Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial","volume":"361","author":"Kerr","year":"2003","journal-title":"Lancet"},{"key":"10.3816\/CCC.2008.n.032_bib72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"Lorenz","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib73","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib74","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.1994.12.11.2288","article-title":"Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma","volume":"12","author":"Kemeny","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib75","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1200\/JCO.2007.12.1764","article-title":"Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?","volume":"25","author":"Mocellin","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib76","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1200\/JCO.2001.19.10.2687","article-title":"Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer","volume":"19","author":"Kemeny","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.20286","article-title":"Hepatic arterial infusion of Floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma","volume":"91","author":"Kemeny","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib78","unstructured":"Huitzil FD, Capanu M, Paty P, et al. Predictive factors for resection of unresectable metastases from colorectal cancer in patients treated with hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) plus IV oxaliplatin (Oxali) and irinotecan (CPT). Presented at: the American Society of Clinical Oncology: 2008 Gastrointestinal Cancers Symposium; January 25-28; Orlando, FL. Abstract 361."},{"key":"10.3816\/CCC.2008.n.032_bib79","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2005.07.100","article-title":"Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer","volume":"23","author":"Kemeny","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib80","first-page":"2033","article-title":"Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer. [in Japanese]","volume":"33","author":"Shitara","year":"2006","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.3816\/CCC.2008.n.032_bib81","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/annonc\/mdm405","article-title":"Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis","volume":"18","author":"Gallagher","year":"2007","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib82","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1440-1746.2005.04023.x","article-title":"Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer","volume":"21","author":"Kim","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3816\/CCC.2008.n.032_bib83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0025-6196(12)60567-9","article-title":"Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver","volume":"60","author":"O'Connell","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CCC.2008.n.032_bib84","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","article-title":"Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial","volume":"24","author":"Portier","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib85","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jamcollsurg.2006.12.036","article-title":"Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents","volume":"204","author":"Parks","year":"2007","journal-title":"J Am Coll Surg"},{"issue":"18 suppl","key":"10.3816\/CCC.2008.n.032_bib86","first-page":"152s","article-title":"Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: A meta-analysis of two randomized trials","volume":"24","author":"Mitry","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib87","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/1097-0142(19860201)57:3<492::AID-CNCR2820570315>3.0.CO;2-M","article-title":"Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries","volume":"57","author":"Kemeny","year":"1986","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib88","first-page":"805","article-title":"Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy","volume":"45","author":"Asahara","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.3816\/CCC.2008.n.032_bib89","first-page":"1499","article-title":"Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy\u2013an intergroup study","volume":"20","author":"Kemeny","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib90","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2008.n.032_bib91","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM200502173520723","article-title":"Hepatic arterial infusion after liver resection","volume":"352","author":"Kemeny","year":"2005","journal-title":"N Eng J Med"},{"key":"10.3816\/CCC.2008.n.032_bib92","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199812000-00006","article-title":"Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)","volume":"228","author":"Lorenz","year":"1998","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib93","first-page":"1685","article-title":"Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study","volume":"48","author":"Lygidakis","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.3816\/CCC.2008.n.032_bib94","first-page":"155","article-title":"Resection versus resection combined with adjuvant pre-and post-operative chemotherapy\u2013immunotherapy for metastatic colorectal liver cancer. A new look at an old problem","volume":"42","author":"Lygidakis","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"10.3816\/CCC.2008.n.032_bib95","first-page":"252","article-title":"Final results of hepatic arterial infusion (HAI) plus systemic (SYS) chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic (M-CRC) to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study","volume":"22","author":"O'Connell","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s004230050199","article-title":"Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases","volume":"384","author":"Rudroff","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"10.3816\/CCC.2008.n.032_bib97","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1549::AID-CNCR8>3.0.CO;2-K","article-title":"Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: a randomized study","volume":"88","author":"Tono","year":"2000","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib98","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1200\/JCO.2003.03.142","article-title":"Phase I\/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer","volume":"21","author":"Kemeny","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib99","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jso.20066","article-title":"Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis","volume":"87","author":"Gardini","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib100","first-page":"124","article-title":"Adjuvant hepatic arterial infusion chemotherapy after curative resection for Dukes C colorectal cancer: a pilot study","volume":"51","author":"Ota","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.3816\/CCC.2008.n.032_bib101","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cncr.11945","article-title":"Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial","volume":"100","author":"Sadahiro","year":"2004","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib102","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/SLA.0b013e31816c405f","article-title":"Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer","volume":"247","author":"Ito","year":"2008","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib103","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1470-2045(00)00419-8","article-title":"Hepatic-arterial chemotherapy","volume":"2","author":"Kemeny","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","article-title":"Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases","volume":"201","author":"Allen","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.3816\/CCC.2008.n.032_bib105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JCO.1993.11.5.822","article-title":"Regional chemotherapy devices: effect of experience and anatomy on complications","volume":"11","author":"Campbell","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib106","first-page":"928","article-title":"Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices","volume":"114","author":"Curley","year":"1993","journal-title":"Surgery"},{"key":"10.3816\/CCC.2008.n.032_bib107","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/msy.2003.37","article-title":"Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases","volume":"133","author":"Heinrich","year":"2003","journal-title":"Surgery"},{"key":"10.3816\/CCC.2008.n.032_bib108","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1245\/ASO.2003.08.019","article-title":"Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer","volume":"10","author":"Scaife","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib109","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U","article-title":"A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer","volume":"69","author":"Kemeny","year":"1992","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1051-0443(97)70547-5","article-title":"Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage","volume":"8","author":"Brown","year":"1997","journal-title":"J Vasc Interv Radiol"},{"key":"10.3816\/CCC.2008.n.032_bib111","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0002-9610(96)00159-6","article-title":"Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity","volume":"172","author":"Davidson","year":"1996","journal-title":"Am J Surg"},{"key":"10.3816\/CCC.2008.n.032_bib112","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.surg.2005.09.023","article-title":"Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases","volume":"139","author":"Tanaka","year":"2006","journal-title":"Surgery"},{"key":"10.3816\/CCC.2008.n.032_bib113","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib114","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.1990.8.6.1108","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"8","author":"Venook","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","article-title":"Treatment of the carcinoid tumor and the malignant carcinoid syndrome","volume":"1","author":"Moertel","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib116","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/SLA.0b013e318155a7b6","article-title":"Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience","volume":"246","author":"Siperstein","year":"2007","journal-title":"Ann Surg"},{"key":"10.3816\/CCC.2008.n.032_bib117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMp048143","article-title":"The price tag on progress\u2013chemotherapy for colorectal cancer","volume":"351","author":"Schrag","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2008.n.032_bib118","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1200\/JCO.1993.11.5.815","article-title":"Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues","volume":"11","author":"Patt","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2008.n.032_bib119","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<882::AID-CNCR12>3.0.CO;2-R","article-title":"Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases","volume":"83","author":"Durand-Zaleski","year":"1998","journal-title":"Cancer"},{"key":"10.3816\/CCC.2008.n.032_bib120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1040-8428(99)00043-8","article-title":"Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer","volume":"32","author":"Durand-Zaleski","year":"1999","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.3816\/CCC.2008.n.032_bib121","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/89.11.790","article-title":"Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer","volume":"89","author":"Durand-Zaleski","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CCC.2008.n.032_bib122","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1016\/S1098-3015(10)67251-8","article-title":"Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)","volume":"8","author":"Weeks","year":"2005","journal-title":"Value Health"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811704285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811704285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:01:15Z","timestamp":1761519675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811704285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1533002811704285"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2008.n.032","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional Chemotherapy for Liver-Limited Metastatic Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2008.n.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}